What do systematic reviews say?

DPP4i vs placebo

DPP4i showed no clear difference in hypoglycaemia compared with placebo (moderate certainty).

• Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2… 2021 · Cochrane Headline outcomes only
  OR 1.11 [0.95, 1.29]
  3 studies · 25842 participants
  Moderate